Mithra Pharmaceuticals S.A. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
558.00
2,928.00
14,267.00
35,976.00
21,081.00
35,457
Depreciation, Depletion & Amortization
591.00
739.00
664.00
1,050.00
2,156.00
2,851
Other Funds
2,562.00
-
-
-
-
21,495
Funds from Operations
151.00
3,133.00
14,050.00
36,831.00
25,528.00
16,813
Changes in Working Capital
491.00
2,234.00
4,621.00
11,881.00
10,664.00
16,731
Net Operating Cash Flow
340.00
899.00
18,671.00
24,950.00
36,192.00
82
Capital Expenditures
832.00
2,147.00
11,461.00
16,104.00
12,198.00
Sale of Fixed Assets & Businesses
16.00
-
911.00
36.00
312.00
Purchase/Sale of Investments
438.00
2,012.00
1,903.00
-
-
Net Investing Cash Flow
1,254.00
8,512.00
33,560.00
24,574.00
11,886.00
Cash Dividends Paid - Total
550.00
2,207.00
-
-
-
Issuance/Reduction of Debt, Net
239.00
536.00
16,322.00
1,520.00
10,630.00
Net Financing Cash Flow
1,773.00
9,528.00
147,345.00
1,520.00
38,517.00
Net Change in Cash
859.00
117.00
95,114.00
51,044.00
9,561.00
Free Cash Flow
228.00
2,188.00
20,857.00
38,745.00
47,135.00
Net Assets from Acquisitions
-
-
18,916.00
8,500.00
-
Other Sources
-
-
787.00
-
-
Change in Capital Stock
-
11,199.00
131,023.00
-
27,887.00
Other Uses
-
4,353.00
2,978.00
6.00
-
About Mithra Pharmaceuticals
View Profile
